The final stages of multiple sclerosis are marked by near-total dependence on others, with the body losing the ability to move, swallow, breathe effectively, and fight off infections. Most people with MS do not die from the disease itself destroying the brain in a sudden catastrophic way. Instead, the accumulating disability creates vulnerabilities, and infections, respiratory failure, or complications of immobility become the immediate threats to life. Understanding what these last stages actually look like, and what causes death, can help families and patients prepare for decisions that are easier to make before a crisis arrives.
What Actually Causes Death in Advanced MS
MS shortens life expectancy, but the disease rarely appears on a death certificate as the sole explanation. In a Finnish study of people diagnosed over three decades, infections of any kind were the leading immediate cause of death, accounting for just over half of all deaths among people with varying levels of disability.1PubMed. End of life in multiple sclerosis: Disability, causes and place of death among cases diagnosed from 1981 to 2010 in Pirkanmaa hospital district in Western Finland A separate population-based analysis found that when MS was listed on a death certificate, aspiration pneumonia was roughly seven times more likely to be a contributing cause of death compared to people without MS, and urinary tract infections were about ten times more likely.2PubMed Central. Multiple cause of death analysis in multiple sclerosis: A population-based study Respiratory infections, sepsis, and skin disease were also significantly elevated in that analysis.
A long-running study from a different population found that cardiovascular disease and cancer still appeared frequently on death certificates alongside MS, accounting for roughly 15% each.3Journal of Neurology, Neurosurgery & Psychiatry. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study In other words, people with advanced MS also die of the same things that kill everyone else. But the infections and respiratory complications that cluster in late-stage disease are disproportionately responsible, and they arise directly from the disability that MS creates.
What the Body Looks Like at the Highest Disability Levels
Clinicians track MS disability with a scale that runs from zero (normal neurological exam) to ten (death from MS). The scores most relevant to end-of-life discussions are roughly 8 through 9.5. At an 8, a person is essentially restricted to a bed or chair for most of the day but still has some use of the arms and can perform limited self-care. At a 9, the person is bedbound and helpless, unable to communicate effectively or eat independently. At 9.5, the person is completely bedbound and unable to communicate or swallow.
A study estimating remaining life expectancy by disability score found that once a person reached a score of 9 to 9.5, with an average age of about 71, the expected remaining life was roughly one additional year.4PubMed. Life expectancy in multiple sclerosis by EDSS score By contrast, at the point where someone first loses the ability to walk independently (a score around 6 to 6.5, typically around age 51 in that cohort), the expected remaining life was over thirteen years. The decline from wheelchair use to total bedbound dependence can span a decade or more, and the rate varies enormously between individuals. But the practical takeaway is that the very final stage, where someone is bedbound and unable to care for themselves at all, tends to be relatively brief.
How Breathing Fails
Respiratory problems are one of the least visible but most dangerous features of advanced MS. The muscles that expand the chest and push air out of the lungs are controlled by nerves running through the spinal cord, and progressive damage to those pathways weakens the entire breathing apparatus. A study comparing ambulatory, wheelchair-bound, and bedridden patients with MS found dramatic differences: ambulatory patients had normal lung function, while bedridden patients had average forced vital capacity of only about 39% of what would be expected for their age and size.5JAMA Neurology. Pulmonary Function and Dysfunction in Multiple Sclerosis Expiratory weakness was the most frequent problem, meaning patients could not cough forcefully enough to clear their airways.
That inability to cough is what makes the late stages so dangerous. Secretions pool in the lungs, food or saliva slips past weakened swallowing muscles, and bacteria find a warm, stagnant environment. Respiratory complications including aspiration, lung infections, and frank respiratory failure are typical in people with longstanding MS.6PubMed. Respiratory dysfunction in multiple sclerosis In some patients, the problem involves not just muscle weakness but also disrupted brain control of breathing itself, with lesions affecting the brainstem centers that regulate respiratory rhythm. A clinical series documented cases where MS caused respiratory arrest, severe drops in oxygen, or carbon dioxide retention from a combination of muscle weakness, bulbar dysfunction, and impaired central control.7Brain. Respiratory Involvement in Multiple Sclerosis
For families, this means that someone in the final stages of MS may develop pneumonia repeatedly. Each episode may be treatable with antibiotics, but over time the lungs become less resilient, and an infection that would be minor for a healthy person becomes life-threatening.
Swallowing Difficulties and Their Consequences
Swallowing is a remarkably complex act that requires precise coordination of muscles in the mouth, throat, and esophagus, all governed by cranial nerves and brainstem circuits that MS can damage. Among a group of 101 people with MS, nearly a third were classified as having swallowing dysfunction, with the most common problem occurring in the throat phase of the swallow. About 7% showed evidence of food or liquid entering the airway.8PubMed. Oropharyngeal dysphagia in multiple sclerosis That figure rises as disability worsens, and in the final stages, dysphagia is nearly universal.
When someone can no longer swallow safely, every meal carries the risk of aspiration pneumonia. This is exactly the chain of events that makes aspiration pneumonia so dramatically overrepresented in MS-related deaths. Families often face a decision about whether to place a feeding tube, usually a gastrostomy tube inserted through the abdominal wall directly into the stomach. The evidence on whether this extends life in advanced MS is limited; a study examining survival after gastrostomy placement in MS patients noted the decision should be informed by each person’s broader clinical picture, though survival data were modest.9PubMed Central. Survival following the placement of gastrostomy tube in patients with multiple sclerosis A feeding tube prevents starvation and dehydration, but it does not eliminate the risk of aspiration, because people still aspirate saliva and oral secretions regardless of how nutrition enters the body.
Cognitive Decline and Dementia
Cognitive problems are common throughout MS, but in the final stages they can deepen into frank dementia. A meta-analysis pooling data from studies that collectively included tens of thousands of people with MS estimated that about 5% had dementia, and that the risk of developing dementia was roughly two-thirds higher than in the general population.10PubMed Central. Dementia in People With Multiple Sclerosis: A Systematic Review and Meta‐Analysis Among those aged 45 to 64 with MS, the rate of early-onset dementia was about seven times higher than in people without MS.
In practical terms, this means some people in the last stages of MS lose the ability to recognize family members, follow conversations, or participate in decisions about their own care. This cognitive decline compounds the challenges of physical dependence, because it can make communication about comfort, pain, and preferences extremely difficult. Families who have discussed end-of-life preferences early, while cognition is still intact, are far better positioned to honor what the person would have wanted.
Spasticity, Pain, and Skin Breakdown
Severe spasticity, where the limbs stiffen into fixed positions, is one of the most distressing features of late-stage MS both for the person experiencing it and for caregivers. Legs may lock into extension or curl into flexion, making positioning in bed or a wheelchair agonizing. A study evaluating intrathecal treatment for severe lower limb spasticity found that a majority of treated patients became easier to position, had fewer spasms, and experienced less pain, with caregivers reporting that washing, dressing, and using a hoist all became safer.11Journal of Neurology, Neurosurgery & Psychiatry. Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? The fact that such interventions are studied tells you how serious the problem gets: these are patients whose limbs have become rigid enough to interfere with basic hygiene and dignified care.
Pressure ulcers are an almost inevitable consequence of prolonged immobility, especially when combined with poor nutrition, incontinence, and reduced sensation. A person who cannot shift their weight in bed develops skin breakdown over bony prominences like the tailbone, heels, and hips, and these wounds can become infected and extremely painful. The population-based death analysis mentioned earlier found that skin disease was about five times more likely to contribute to death when MS was present.2PubMed Central. Multiple cause of death analysis in multiple sclerosis: A population-based study Pressure ulcers don’t often kill on their own, but they provide another gateway for the infections that do.
Autonomic Nervous System Breakdown
The autonomic nervous system manages blood pressure, heart rate, bladder function, bowel motility, and temperature regulation, and MS can quietly degrade all of these. Cardiovascular autonomic dysfunction has been found in roughly two-thirds of people with MS, and orthostatic hypotension, where blood pressure drops dangerously when sitting or standing, affects about half.12Annals of Clinical Neurophysiology. Autonomic dysfunction in multiple sclerosis and neuromyelitis optica spectrum disorder Many of these findings are subclinical earlier in the disease, meaning they show up on testing but the person hasn’t noticed symptoms yet.
In the last stages, autonomic dysfunction becomes harder to ignore. Bladder dysfunction leads to chronic urinary retention or incontinence, which in turn leads to the recurrent urinary tract infections that are so overrepresented in MS deaths. Bowel dysfunction can cause severe constipation or fecal incontinence. Temperature regulation may fail, leaving the person vulnerable to dangerous overheating or hypothermia. Heart rate variability diminishes, and while the relationship between autonomic cardiovascular changes and sudden death in MS is not fully established, the cardiovascular system’s ability to respond to stress is clearly impaired.13PubMed. Multiple sclerosis and the autonomic nervous system
When Palliative Care Should Begin
There is a widespread misconception that palliative care means giving up or waiting to die. In MS, the evidence suggests it should start much earlier than most people assume. A survey of healthcare professionals found that roughly 80 to 87% believed specialized palliative care should begin once the disease has progressed to the point where someone needs regular nursing care and has lost independent mobility.14PubMed Central. Palliative Care for Severely Affected Patients with Multiple Sclerosis: When and Why? Results of a Delphi Survey of Health Care Professionals The professionals identified communication about disease progression, psychological support, support for relatives, and pain management as the key triggers for bringing in a palliative team. Almost all of them rated specialized palliative home care as very important.
A randomized trial tested short-term palliative care for people severely affected by MS, with participants averaging a disability score of about 7.7, meaning most were wheelchair-bound with significant upper-body involvement. After a palliative care team provided an average of three visits over six weeks, both symptom scores and caregiver burden improved. Notably, earlier referral had a bigger effect on reducing caregiver strain. The benefits lasted about six weeks after the palliative team withdrew but then faded, suggesting that ongoing rather than one-shot involvement is needed.15Postgraduate Medical Journal. Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained A scoping review of the broader literature reinforced that people with MS should have access to specialized palliative care once they reach the severe phase, delivered by a multidisciplinary team that can address the full range of symptoms.16Annals of Palliative Medicine. Integrating palliative care in patients with advanced multiple sclerosis: a scoping review
Recognizing the Dying Trajectory
One of the challenges in MS is that the decline toward death is rarely a smooth downward slope. Researchers have described a pattern called “progressive dwindling,” where a person gradually loses function over months to years through a series of small setbacks rather than a single dramatic event. A study analyzing this trajectory found that earlier disease milestones, including age at onset, the point at which disability began progressing, and when wheelchair use started, could help predict who was on a dwindling course.17PubMed Central. Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care Identifying this pattern is valuable because it allows clinicians and families to begin planning before a crisis forces rushed decisions.
In practice, the signs that someone is approaching the final months often include repeated hospitalizations for pneumonia or urinary sepsis, inability to take food by mouth, worsening confusion or withdrawal, and skin breakdown that no longer heals well. No single sign is definitive, but the accumulation of these problems, especially when each hospitalization leaves the person weaker than before, signals that the end of life is near.
Stopping Disease-Modifying Drugs
People with MS often take disease-modifying therapies for years or decades, and families sometimes worry about the moment those drugs are discontinued. In late-stage disease, when the person is bedbound and the disease has long since transitioned from relapsing to progressive, these medications offer little benefit because there is no longer active inflammation to suppress. A study of patients who stopped their disease-modifying therapy found that in older patients with no evidence of recent inflammatory activity, the drugs could be stopped safely, with nearly 90% remaining free of any new inflammatory event.18PubMed Central. Stopping Disease-Modifying Therapy in Nonrelapsing Multiple Sclerosis: Experience from a Clinical Practice Stopping these medications in the final stages is not abandonment. It is a recognition that the disease has moved beyond what those drugs were designed to address, and that comfort-focused care is more appropriate.
The Weight on Caregivers
The final stages of MS place enormous strain on family caregivers, who often find themselves managing round-the-clock physical care, medication schedules, wound care, and emotional support with little respite. A qualitative study of caregivers revealed pervasive fatigue driven by the unrelenting management of care responsibilities. Caregivers described being exhausted not only by the physical labor but also by the constant mental burden of tracking treatments, appointments, and contingencies.19PLoS ONE. Burden and resources in caregivers of people with multiple sclerosis: A qualitative study Perhaps most poignantly, many expressed deep anxiety about the future, worrying about who would care for their family member if the caregiver themselves became ill or died.
Caregiver burnout in late-stage MS is a legitimate medical concern in its own right. Overwhelmed caregivers are more likely to make errors in medication or positioning, less likely to seek help before a problem becomes an emergency, and at higher risk for their own depression and physical decline. The palliative care trial described earlier found that earlier referral to a palliative team was especially effective at reducing caregiver burden, suggesting that formal support systems can make a meaningful difference even when the disease itself cannot be reversed.
End-of-Life Conversations and Assisted Dying
As disability progresses, many people with MS think seriously about what kind of end they want. In countries and jurisdictions where medical assistance in dying is legal, some people with MS choose this option. A study exploring hypothetical scenarios found that unbearable pain was the most common reason participants said they would consider assisted dying, followed by the need for continuous care and the perception of being a burden to others. Fewer said that loss of pleasurable activities alone or a change in living arrangements would prompt the decision.20Canadian Journal of Occupational Medicine. Navigating End-of-Life Choices: Perspectives of Individuals Living with Multiple Sclerosis on Medical Assistance in Dying in Various Hypothetical Situations The reasoning was deeply personal, shaped by guilt about burdening family, shifting identity as the disease took away independence, and uneven access to care resources.
Regardless of whether assisted dying is legally available or personally acceptable, the broader point is that ongoing end-of-life communication matters. MS carries a risk of fluctuating cognitive capacity, which means a person who can articulate their wishes today may not be able to do so in six months. Researchers have stressed that because of this complexity, conversations about end-of-life preferences should be revisited regularly throughout the disease course rather than deferred to a single dramatic moment.21PubMed Central. End-of-life communication in the context of MAID: a qualitative study on the perspectives and preferences of individuals living with MS Advance directives that specify preferences about feeding tubes, ventilators, resuscitation, and hospitalization can prevent families from having to make agonizing decisions under pressure.
Rare Rapidly Progressive Variants
Everything described above assumes the typical MS course, where disability accumulates over years to decades. A small number of people experience a rare variant called Marburg MS, which behaves very differently. This fulminant form of the disease progresses from onset to severe disability or death within weeks to months, bypassing the slow accumulation of disability entirely.22PubMed. Towards practical management of the Marburg variant of multiple sclerosis Marburg MS involves massive, widespread demyelination that can mimic a brain tumor or acute encephalitis. Some patients have responded to aggressive immunosuppression, but historically the variant has carried a very poor prognosis.23PubMed Central. A Patient with Marburg’s Variant of Multiple Sclerosis Responded Well to Cyclophosphamide Marburg MS is extremely uncommon, but it is worth knowing about because its timeline is so different from what families with typical MS expect. The last stages of Marburg MS may compress into days what ordinarily unfolds over years.